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STATE-OF-THE-ART PAPERS STATE-OF-THE-ART PAPERSmiRNAs in Cardiovascular Diseases 2177
Gianluigi Condorelli, Michael V. G. Latronico, Elena Cavarretta
Over the last few years, the understanding of the role of microribonucleic acids (miRNAs)
in cardiovascular biology and disease has expanded at an incredible pace. miRNAs are
w22-nucleotide-long ribonucleic acid (RNA) sequences that can ligate messenger RNAs at
partially complementary binding sites and, hence, can regulate the rate of protein synthesis.
In the cardiovascular system, miRNAs are critical regulators of development and physiology;
they control basic functions in virtually all cell types. Condorelli and colleagues review the role
of miRNA in the pathophysiology of many cardiovascular diseases and the possibility of using
miRNA for diagnosis and for prognosis and therapeutically.STATE-OF-THE-ART PAPERSTargeting the Interstitium in Heart Failure 2188Erik B. Schelbert, Gregg C. Fonarow, Robert O. Bonow, Javed Butler, Mihai Gheorghiade
Improved left ventricular structural characterization may permit the identiﬁcation and
targeting of the intrinsic fundamental disease pathways that culminate in heart failure.
“Interstitial heart disease” is one such pathway, characterized by extracellular matrix (ECM)
expansion that is associated with mechanical, electrical, and vasomotor dysfunction and
adverse outcomes. Advances in cardiovascular magnetic resonance now enable clinicians and
researchers to assess the interstitium and quantify ECM expansion and other derangements
in cardiovascular structure. These capabilities may provide a mechanistic platform to advance
the understanding of the role of the ECM, foster the development of novel therapeutics, and
target speciﬁc disease-modifying pathways intrinsic to the ventricle.VIEWPOINT VIEWPOINTChallenges Facing Early Career Academic Cardiologists 2199
Carl W. Tong, Tariq Ahmad, Evan L. Brittain, T. Jared Bunch, Julie B. Damp, Todd Dardas,
Amalea Hijar, Joseph A. Hill, Anthony A. Hilliard, Steven R. Houser, Eiman Jahangir,
Andrew M. Kates, Darlene Kim, Brian R. Lindman, John J. Ryan, Anne K. Rzeszut,
Chittur A. Sivaram, Anne Marie Valente, Andrew M. Freeman
Early-career academic cardiologists currently face unprecedented challenges. A team
consisting of early-career professionals and senior leadership members of the American
College of Cardiology completed this viewpoint paper to inform the cardiovascular medicine
profession regarding the plight of early-career cardiologists and to suggest possible solutions.(continued on page A-27)
JUNE 3, 2014 (continued) A-27CLINICAL RESEARCH CORONARY ARTERY DISEASEMorphological Features of Ruptured Culprit Plaque 2209Jinwei Tian, Xuefeng Ren, Rocco Vergallo, Lei Xing, Huai Yu, Haibo Jia, Tsunenari Soeda,
Iris McNulty, Sining Hu, Hang Lee, Bo Yu, Ik-Kyung Jang
Tian and colleagues used optical coherence tomography and intravascular ultrasound to
compare morphologic characteristics of ruptured culprit plaques (RCP), ruptured nonculprit
plaques (RNCP), and nonruptured thin-cap ﬁbroatheroma (TCFA) in patients presenting
with acute coronary syndromes (ACS). The ﬁbrous cap was thinner in RCP and RNCP than
in TCFA. Plaque burden was greater in RCP than in RNCP and TCFA. A ﬁbrous cap
thickness <52 mm discriminated ruptured plaque from TCFA. A plaque burden >76% and a
lumen area <2.6 mm2 discriminated RCP from RNCP and TCFA. These ﬁndings suggest
that plaque rupture is determined by ﬁbrous cap thickness, and that a combination of large
plaque burden and luminal narrowing results in ACS.
Editorial Comment: Francesco Prati, Mario Albertucci, p. 2217CORONARY ARTERY DISEASEIVUS Signatures of Ruptured Plaques 2220Jun Pu, Gary S. Mintz, Sinan Biro, Jin-Bae Lee, Stephen T. Sum, Sean P. Madden, Allen P. Burke,
Pei Zhang, Ben He, James A. Goldstein, Gregg W. Stone, James E. Muller, Renu Virmani,
Akiko Maehara
Three intravascular ultrasound (IVUS) signatures have been associated with coronary artery
disease instability: echo attenuation, intraplaque echolucent zone, and spotty calciﬁcation. Pu
and colleagues investigated the substrates responsible for these IVUS signatures in a relatively
large series of post-mortem human coronary samples. Echo-attenuated plaques corresponded
to either a ﬁbroatheroma with a necrotic core or pathologic intimal thickening with a lipid
pool. Echolucent plaques indicated the presence of a relatively smaller lipid/necrotic core.
This study demonstrates that echo-attenuated plaque, especially superﬁcial echo attenuation,
was the most reliable IVUS signature for identifying a high-risk plaque.(continued on page A-28)
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Riyaz S. Patel, Folkert W. Asselbergs, Arshed A. Quyyumi, Tom M. Palmer, Chris I. Finan,
Vinicius Tragante, John Deanﬁeld, Harry Hemingway, Aroon D. Hingorani, Michael V. Holmes
Patel and colleagues performed a meta-analysis to compare the association between variants
at the chromosome 9p21 locus (Ch9p21) and the risk of ﬁrst and subsequent coronary heart
disease (CHD) events. A total of 31 cohorts reporting on 193,372 individuals were analyzed.
Ch9p21 was associated with a pooled hazard ratio of a ﬁrst event of 1.19 per risk allele. In
individuals with established CHD (n ¼ 25,163), there was sufﬁcient power to detect an
increased hazard, but none was present. Ch9p21 is associated with the risk of ﬁrst versus
subsequent CHD events. This has implications for the mechanistic understanding of how
Ch9p21 inﬂuences the risk of CHD.
Editorial Comment: Benjamin D. Horne, p. 2246CORONARY ARTERY DISEASEClopidogrel in UA/NSTEMI 2249
Matthew D. Solomon, Alan S. Go, David Shilane, Derek B. Boothroyd, Thomas K. Leong,
Dhruv S. Kazi, Tara I. Chang, Mark A. Hlatky
Solomon and colleagues reviewed data from the Kaiser Permanente system to examine
the effectiveness of clopidogrel in real-world, medically managed patients with unstable
angina (UA) or non–ST-segment elevation myocardial infarction (NSTEMI). More than
15,000 subjects without previous coronary artery disease were diagnosed with UA or
NSTEMI and were then followed for 2 years. Approximately one-third of subjects were
prescribed clopidogrel. In a propensity score-matched analysis, clopidogrel users had lower
rates of all-cause mortality and the composite of death or myocardial infarction (MI), but
not of MI alone. In a large, community-based cohort of patients medically managed after
UA/NSTEMI, clopidogrel use was associated with a lower risk of death and MI, particularly
among NSTEMI patients.
Editorial Comment: E. Magnus Ohman, Ralf E. Harskamp, p. 2258(continued on page A-29)
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Ge Gao, Vikram Brahmanandam, Mihai Raicu, Lianzhi Gu, Li Zhou, Srinivasan Kasturirangan,
Anish Shah, Smita I. Negi, Melissa R. Wood, Ankit A. Desai, Antone Tatooles, Alan Schwartz,
Samuel C. Dudley, Jr
Heart failure (HF) is associated with up-regulation of 2 cardiac SCN5A messenger
ribonucleic acid splice variants that encode prematurely truncated, nonfunctional Naþ
channels. Since circulating white blood cells (WBCs) demonstrate similar SCN5A splicing
patterns, Gao and colleagues hypothesized that these WBC-derived splice variants might
further stratify the risk for arrhythmias in patients with HF. Simultaneously obtained
myocardial core samples and WBCs were compared for SCN5A variants. Myocardial
tissue-derived SCN5A variant expression levels were strongly correlated with circulating
WBC samples. After controlling for covariates, SCN5A variant levels were highly predictive
of risk for appropriate implantable cardioverter-deﬁbrillator intervention (area under the
curve 0.97).
Editorial Comment: Heikki V. Huikuri, p. 2270HEART RHYTHM DISORDERSDrug-Induced Brugada Syndrome in Children 2272
Giulio Conte, Wendy Dewals, Juan Sieira, Carlo de Asmundis, Giuseppe Ciconte, Gian-Battista Chierchia,
Giacomo Di Giovanni, Giannis Baltogiannis, Yukio Saitoh, Moises Levinstein, Mark La Meir,
Francis Wellens, Gudrun Pappaert, Pedro Brugada
Conte and colleagues investigated the clinical features, management, and long-term follow-
up of children with drug-induced Brugada syndrome (BS). A total of 40 children (60% male,
mean age 8 years) were included, of which 5% had a previous episode of aborted sudden
death and 20% had syncope. Children more frequently presented with sinus node dysfunction
and more frequently experienced episodes of ajmaline-induced sustained ventricular
arrhythmias as compared with older patients. Among children with implantable cardioverter-
deﬁbrillators (ICDs), 1 (8%) experienced an appropriate shock, 4 (33%) had inappropriate
ICD shocks, and 4 (33%) experienced device-related complications. Based on these ﬁndings,
the optimal management of BS in children should be individualized, taking into
consideration the patient’s clinical history and the family’s wishes.(continued on page A-30)
JUNE 3, 2014 (continued) A-30CARDIAC SURGERYSurvival Better After On-Pump Than Off-Pump Coronary Surgery 2280
Joon Bum Kim, Sung-Cheol Yun, Jae Wong Lim, Soo Kyung Hwang, Sung-Ho Jung, Hyun Song,
Cheol Hyun Chung, Jae Won Lee, Suk Jung Choo
Kim and colleagues compared long-term survival after off- and on-pump coronary artery
bypass grafting (CABG) in a large, nonrandomized cohort of patients. Over 5,000 subjects
who underwent elective isolated CABG (off-pump, n ¼ 2,333; on-pump, n ¼ 2,870) from
1989 through 2012 were followed for mortality. Long-term survival was compared with the
use of propensity scores and inverse probability weighting to adjust selection bias. After
adjustment, both groups of patients showed a similar risk of death at 30 days and up to 1 year.
However, patients undergoing off-pump CABG were at a signiﬁcantly higher risk of death
during long-term follow-up (hazard ratio: 1.43).CARDIORESPIRATORY FITNESSEstimated Cardiorespiratory Fitness and Cardiovascular Outcomes 2289
Enrique G. Artero, Andrew S. Jackson, Xuemei Sui, Duck-Chul Lee, Daniel P. O’Connor,
Carl J. Lavie, Timothy S. Church, Steven N. Blair
Artero and colleagues sought to determine whether a formula could be derived that would
predict risk of nonfatal cardiovascular disease (CVD) and disease-speciﬁc mortality using
cardiorespiratory ﬁtness (CRF) algorithms that do not involve exercise testing. Estimated
CRF was based on sex, age, body mass index, waist circumference, resting heart rate, physical
activity level, and smoking status. Actual CRF was measured by a maximal treadmill test in
more than 40,000 subjects. After adjusting for potential confounders, both measured and
estimated CRF were inversely associated with risk of all-cause mortality and nonfatal CVD
incidence in both men and women. Measured CRF had a slightly better discriminative ability
(c-statistic) than estimated CRF. These algorithms utilize information that is routinely
collected to obtain an estimate of CRF that provides a valid indication of health status
and future risk.
